LEVEMIR Safety Questions, LEVEMIR Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LEVEMIR. Our extensive database of LEVEMIR adverse events and LEVEMIR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LEVEMIR

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



LEVEMIR Safety Reports

Total LEVEMIR reports: 1163.
LEVEMIR FDA safety alerts: No.
Reported deaths: 19    Reported hospitalizations: 100.
Take LEVEMIR Side Effects Survey or Share Your LEVEMIR Story. LEVEMIR Usage.

Showing 1-75 of 1163 Next >

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 17, 2006. Male patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 78 years of age, weighting 155.9 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with METFORMIN, NOVOFINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 31, 2006. Female patient, 72 years of age, weighting 162.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site swelling. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2006. Female patient, 63 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased. LEVEMIR dosage: unknown. During the same period patient was treated with HUMALOG, ACTONEL, SYNTHROID, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 02, 2006. Female patient, 59 years of age, weighting 160.1 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG FLEXPEN. Patient recovered.

LEVEMIR problem was reported by a Physician from UNITED STATES on Oct 18, 2006. Female patient, 48 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with METFORMIN. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Nov 15, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site urticaria. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 16, 2006. Male patient, 57 years of age, weighting 261.9 lb, was diagnosed with blood insulin, diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG, ZOCOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 17, 2006. Female patient, 55 years of age, weighting 274.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site pruritus. LEVEMIR dosage: unknown. During the same period patient was treated with AVANDAMET, SIMVASTATIN, TORSEMIDE, QUINAPRIL. Patient recovered.

LEVEMIR problem was reported by a Pharmacist from UNITED STATES on Nov 17, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site erythema. LEVEMIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 16, 2006. Male patient, 79 years of age, weighting 175.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with GLYBURIDE, NOVOFINE R. Patient recovered.

LEVEMIR problem was reported by a Pharmacist from UNITED STATES on Nov 17, 2006. Female patient, 56 years of age, was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site erythema. LEVEMIR dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported LEVEMIR problem on Nov 20, 2006. Male patient, 67 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOFINE R. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2006. Female patient, 70 years of age, weighting 170.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: rash. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG, ZESTRIL, LIPITOR, AMARYL, METFORMIN, AVANDIA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 06, 2006. Male patient, 72 years of age, weighting 216.1 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with STARLIX. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2006. Female patient, 69 years of age, weighting 162.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: weight increased. LEVEMIR dosage: unknown. During the same period patient was treated with QUINAPRIL, LIPITOR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 08, 2006. Female patient, 52 years of age, weighting 207.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLIN R. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2006. Female patient, 70 years of age, weighting 140.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site erythema, injection site pruritus, injection site swelling. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG PENFILL. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Nov 02, 2006. Female patient, 70 years of age, weighting 181.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: pruritus, rash. LEVEMIR dosage: unknown. During the same period patient was treated with LASIX. Patient recovered.

LEVEMIR problem was reported by a Physician from UNITED STATES on Nov 02, 2006. Male patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: skin reaction. LEVEMIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 10, 2006. Male patient, 81 years of age, weighting 200.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2006. Male patient, 51 years of age, weighting 325.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site rash. LEVEMIR dosage: unknown. During the same period patient was treated with GLIPIZIDE, ZOCOR, QUINARETIC. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 15, 2006. Female patient, 56 years of age, weighting 308.9 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site erythema, injection site pruritus. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2006. Male patient, 67 years of age, weighting 160.1 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with HUMALOG. Patient recovered.

Pharmacist from UNITED STATES reported LEVEMIR problem on Nov 16, 2006. Female patient, 52 years of age, was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOFINE. Patient recovered.

LEVEMIR problem was reported by a Health Professional from UNITED STATES on Nov 09, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. LEVEMIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 14, 2006. Male patient was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site erythema, injection site pain, injection site pruritus. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOFINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 15, 2006. Female patient was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2006. Male patient, 51 years of age, weighting 200.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site mass. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOFINE, PROZAC, ALTACE. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Nov 15, 2006. Male patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2006. Female patient, 56 years of age, weighting 160.1 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. During the same period patient was treated with GLUCOPHAGE, ACTOS, LANTUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 22, 2006. Female patient, 69 years of age, weighting 162.9 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Female patient, 74 years of age, weighting 157.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Nov 27, 2006. Male patient, 68 years of age, weighting 235.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2006. Male patient, 44 years of age, weighting 360.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, weight increased. LEVEMIR dosage: unknown. During the same period patient was treated with ACTOS. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Dec 13, 2006. Female patient, 60 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: rash. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Physician from UNITED STATES on Dec 18, 2006. Male patient, 64 years of age, was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site reaction. LEVEMIR dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Dec 19, 2006. Male patient, 52 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site reaction. LEVEMIR dosage: unknown. During the same period patient was treated with AVANDIA, METFORMIN, PRINIVIL. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2006. Female patient, 71 years of age, weighting 253.5 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG FLEX PEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Dec 21, 2006. Female patient, child 11 years of age, weighting 114.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG. Patient recovered.

LEVEMIR problem was reported by a Health Professional from UNITED STATES on Dec 12, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site pain, injection site swelling. LEVEMIR dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Dec 15, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: pruritus, rash. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG, APIDRA. Patient recovered.

LEVEMIR problem was reported by a Physician from UNITED STATES on Dec 15, 2006. Female patient was diagnosed with diabetes mellitus, diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: pruritus, rash. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 01, 2006. Male patient, 62 years of age, weighting 194.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: nervousness, restlessness. LEVEMIR dosage: unknown. During the same period patient was treated with HUMALOG, ATACAND, MONOPRIL. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 27, 2006. Male patient, 48 years of age, weighting 282.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, injection site bruising. LEVEMIR dosage: unknown. During the same period patient was treated with HYDROCODONE W. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Oct 18, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2006. Male patient, 70 years of age, weighting 215.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: dizziness. LEVEMIR dosage: unknown. During the same period patient was treated with ACTOS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 16, 2006. Female patient, 52 years of age, weighting 136.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: appetite disorder, weight decreased, weight increased. LEVEMIR dosage: unknown. During the same period patient was treated with AVANDIA, ALTACE. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 54 years of age, weighting 188.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: headache, nausea, restlessness. LEVEMIR dosage: unknown. During the same period patient was treated with GLUCOPHAGE, GLYBURIDE, COZAAR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Nov 02, 2006. Female patient, 76 years of age, weighting 194.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site haemorrhage. LEVEMIR dosage: unknown. During the same period patient was treated with ASPIRIN. Patient recovered.

LEVEMIR problem was reported by a Pharmacist from UNITED STATES on Nov 07, 2006. Female patient, 66 years of age, was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: anxiety, blood pressure increased, insomnia. LEVEMIR dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported LEVEMIR problem on Nov 08, 2006. Male patient, 66 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, blood glucose increased, burning sensation, weight decreased. LEVEMIR dosage: unknown. During the same period patient was treated with LANTUS, ASPIRIN. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 03, 2006. Female patient, 53 years of age, weighting 252.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LEVEMIR dosage: unknown. During the same period patient was treated with TOPROL, ASPIRIN, GLUCOPHAGE, LOTREL, GLUCOSAMINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 23, 2006. Male patient, 65 years of age, weighting 190.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site haemorrhage. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2006. Female patient, 64 years of age, weighting 269.8 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: acne, blood glucose increased, pruritus. LEVEMIR dosage: unknown. During the same period patient was treated with ACTOS, GLIPIZIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 03, 2006. Female patient, 80 years of age, weighting 186.1 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site haemorrhage. LEVEMIR dosage: unknown. During the same period patient was treated with GLIPIZIDE, FUROSEMIDE, METOPROLOL TARTRATE, COUMADIN. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Female patient, 69 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site bruising, injection site haemorrhage. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOFINE, ACTOS, LIMOXIN, ALLEGRA, LIBRIUM, CELEBREX, EFFEXOR, EVISTA. Patient recovered.

Health Professional from UNITED STATES reported LEVEMIR problem on Oct 25, 2006. Male patient, 65 years of age, weighting 284.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood pressure decreased. LEVEMIR dosage: unknown. During the same period patient was treated with DIAMOX, VICODIN, METFORMIN, FUROSEMIDE, SIMVASTATIN, BENICAR. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 27, 2006. Male patient, 64 years of age, weighting 259.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, injection site bruising, medical device complication. LEVEMIR dosage: unknown. During the same period patient was treated with GLYSET, COZAAR, CRESTOR, COREG, AMBIEN, SPIRONOLACTONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 31, 2006. Female patient, 60 years of age, weighting 289.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: myalgia. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2006. Female patient, child 3 years of age, weighting 37.92 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood glucose increased, insomnia, rash, thirst. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Oct 25, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: dyspnoea. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Physician from UNITED STATES on Oct 25, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: dysgeusia. LEVEMIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 02, 2006. Female patient, 75 years of age, was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site bruising. LEVEMIR dosage: unknown. During the same period patient was treated with DIURETICS. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2006. Female patient, 59 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site discharge, injection site haemorrhage. LEVEMIR dosage: unknown. During the same period patient was treated with ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 04, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: sensory disturbance. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Physician from UNITED STATES on Oct 05, 2006. Female patient was diagnosed with diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site swelling, pharyngeal oedema. LEVEMIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 05, 2006. Female patient, 56 years of age, weighting 151.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: insomnia. LEVEMIR dosage: unknown. During the same period patient was treated with CRESTOR, ACIPHEX. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 06, 2006. Female patient, 61 years of age, weighting 160.1 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: headache. LEVEMIR dosage: unknown. During the same period patient was treated with HUMALOG. Patient recovered.

Physician from UNITED STATES reported LEVEMIR problem on Oct 11, 2006. Female patient was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site haematoma. LEVEMIR dosage: unknown. Patient recovered.

LEVEMIR problem was reported by a Physician from UNITED STATES on Oct 11, 2006. Male patient was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: asthenia. LEVEMIR dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Oct 05, 2006. Male patient, 81 years of age, weighting 157.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation, stomach discomfort. LEVEMIR dosage: unknown. During the same period patient was treated with NOVOLOG FLEXPEN, NOVOFINE. Patient recovered.

LEVEMIR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 20, 2006. Female patient, 43 years of age, weighting 134.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site bruising. LEVEMIR dosage: unknown. During the same period patient was treated with ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVEMIR problem on Dec 11, 2006. Male patient, 78 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with LEVEMIR. After drug was administered, patient experienced the following problems/side effects: injection site bruising. LEVEMIR dosage: unknown. During the same period patient was treated with PLAVIX. Patient recovered.

Showing 1-75 of 1163 Next >

Ask Our Patient Community about LEVEMIR

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top